These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23963609)

  • 21. Impulsive and compulsive behaviors among Danish patients with Parkinson's disease: prevalence, depression, and personality.
    Callesen MB; Weintraub D; Damholdt MF; Møller A
    Parkinsonism Relat Disord; 2014 Jan; 20(1):22-6. PubMed ID: 24090948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenomenology and treatment of behavioural addictions.
    Grant JE; Schreiber LR; Odlaug BL
    Can J Psychiatry; 2013 May; 58(5):252-9. PubMed ID: 23756285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurobiology of pathological gambling.
    Potenza MN
    Semin Clin Neuropsychiatry; 2001 Jul; 6(3):217-26. PubMed ID: 11447573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.
    Bienfait KL; Menza M; Mark MH; Dobkin RD
    J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors.
    Antons S; Brand M; Potenza MN
    J Neurol Sci; 2020 Aug; 415():116952. PubMed ID: 32534370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
    Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
    Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study.
    Pettorruso M; Martinotti G; Fasano A; Loria G; Di Nicola M; De Risio L; Ricciardi L; Conte G; Janiri L; Bentivoglio AR
    Psychiatry Res; 2014 Feb; 215(2):448-52. PubMed ID: 24373553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.
    Fontenelle LF; Oostermeijer S; Harrison BJ; Pantelis C; Yücel M
    Drugs; 2011 May; 71(7):827-40. PubMed ID: 21568361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity.
    Leeman RF; Potenza MN
    Psychopharmacology (Berl); 2012 Jan; 219(2):469-90. PubMed ID: 22057662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linking brain activity during sequential gambling to impulse control in Parkinson's disease.
    Haagensen BN; Herz DM; Meder D; Madsen KH; Løkkegaard A; Siebner HR
    Neuroimage Clin; 2020; 27():102330. PubMed ID: 32688307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impulsive and compulsive behaviors in Parkinson's disease.
    Evans AH; Strafella AP; Weintraub D; Stacy M
    Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease.
    Paz-Alonso PM; Navalpotro-Gomez I; Boddy P; Dacosta-Aguayo R; Delgado-Alvarado M; Quiroga-Varela A; Jimenez-Urbieta H; Carreiras M; Rodriguez-Oroz MC
    Mov Disord; 2020 Feb; 35(2):316-325. PubMed ID: 31710401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease.
    Biundo R; Weis L; Facchini S; Formento-Dojot P; Vallelunga A; Pilleri M; Weintraub D; Antonini A
    Mov Disord; 2015 Apr; 30(5):688-95. PubMed ID: 25649923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review.
    Fineberg NA; Potenza MN; Chamberlain SR; Berlin HA; Menzies L; Bechara A; Sahakian BJ; Robbins TW; Bullmore ET; Hollander E
    Neuropsychopharmacology; 2010 Feb; 35(3):591-604. PubMed ID: 19940844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
    Fenu S; Wardas J; Morelli M
    Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches.
    Jiménez-Urbieta H; Gago B; de la Riva P; Delgado-Alvarado M; Marin C; Rodriguez-Oroz MC
    Neurosci Biobehav Rev; 2015 Sep; 56():294-314. PubMed ID: 26216865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Decision Making Research Provide a Better Understanding of Chemical and Behavioral Addictions?
    Engel A; Cáceda R
    Curr Drug Abuse Rev; 2015; 8(2):75-85. PubMed ID: 26373849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
    Cabrini S; Baratti M; Bonfà F; Cabri G; Uber E; Avanzi M
    Neurol Sci; 2009 Aug; 30(4):307-13. PubMed ID: 19513585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.